Peter Johnson

Peter Johnson

University of Bath

H-index: 55

Europe-United Kingdom

About Peter Johnson

Peter Johnson, With an exceptional h-index of 55 and a recent h-index of 29 (since 2020), a distinguished researcher at University of Bath, specializes in the field of HCI.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pilot Randomized Controlled Trial of an Educational Video for CAR T-Cell Therapy Recipients

Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T-cell Therapy

KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes

Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy

The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer

Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells

Clinical Outcomes and Health Care Utilization in Patients With Burkitt Lymphoma

Peter Johnson Information

University

Position

Professor of Computing Science

Citations(all)

13667

Citations(since 2020)

3801

Cited By

12901

hIndex(all)

55

hIndex(since 2020)

29

i10Index(all)

224

i10Index(since 2020)

84

Email

University Profile Page

University of Bath

Google Scholar

View Google Scholar Profile

Peter Johnson Skills & Research Interests

HCI

Top articles of Peter Johnson

Title

Journal

Author(s)

Publication Date

Pilot Randomized Controlled Trial of an Educational Video for CAR T-Cell Therapy Recipients

Journal of the National Comprehensive Cancer Network

P Connor Johnson

Tejaswini Dhawale

Richard A Newcomb

Ana Barata

Kyle Karpinski

...

2024/2/27

Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T-cell Therapy

Transplantation and Cellular Therapy

P Connor Johnson

Isabel Neckermann

Hossein Sadrzadeh

Richard Newcomb

Areej R El-Jawahri

...

2024/2/25

KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes

Clinical Cancer Research

Bimarzhan Assatova

Robert Willim

Christopher Trevisani

Garrett Haskett

Khyati Maulik Kariya

...

2024/2/9

Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Transplantation and Cellular Therapy

Tejaswini Dhawale

P Connor Johnson

Kofi Boateng

Anna Barata

Lara Traeger

...

2024/1/21

Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy

Anna Barata

Tejaswini Dhawale

Richard A Newcomb

Hermioni L Amonoo

Ashley M Nelson

...

2024/1/17

The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer

The Oncologist

Sunil Bhatt

P Connor Johnson

Netana H Markovitz

Tamryn Gray

Ryan D Nipp

...

2023/2/1

Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells

Neuro-oncology

Philipp Karschnia

Isabel C Arrillaga-Romany

April Eichler

Deborah A Forst

Elizabeth Gerstner

...

2023/12/1

Clinical Outcomes and Health Care Utilization in Patients With Burkitt Lymphoma

JCO Oncology Practice

P Connor Johnson

Netana H Markovitz

Alisha Yi

Nora Horick

Richard A Newcomb

...

2023/9

SALVAGE RADIOTHERAPY IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA AFTER CAR T‐CELL THERAPY FAILURE

Haematologica

Hazim S Ababneh

Andrea K Ng

Matthew J Frigault

Jeremy S Abramson

Patrick Connor Johnson

...

2023/11/11

Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation

Blood Advances

Hermioni L Amonoo

P Connor Johnson

Ashley M Nelson

Madison A Clay

Elizabeth Daskalakis

...

2023/4/11

Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy

Blood Advances

P Connor Johnson

Tejaswini Dhawale

Richard A Newcomb

Hermioni L Amonoo

Mitchell W Lavoie

...

2023/7/25

Quality of life, physical functioning, and psychological distress of older adults undergoing hematopoietic stem cell transplantation

Transplantation and cellular therapy

Richard Newcomb

P Connor Johnson

Katherine Cronin

Joanna J Choe

Katherine Holmbeck

...

2023/6/1

Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin’s Lymphoma

The Oncologist

Richard A Newcomb

P Connor Johnson

Daniel Yang

Katherine Holmbeck

Joanna Choe

...

2023/11/3

Clinical Features of AKI in the Early Post-Transplant Period Following Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

Transplantation and Cellular Therapy

J Vergara-Cadavid

PC Johnson

HT Kim

A Yi

ME Sise

...

2023/4/2

Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia

Journal of Geriatric Oncology

P Connor Johnson

Jennifer A Woyach

Angela Ulrich

Veronique Marcotte

Ryan D Nipp

...

2023/7/1

Delirium and Healthcare Utilization in Patients Undergoing Hematopoietic Stem Cell Transplantation

Transplantation and Cellular Therapy

Hermioni L Amonoo

Netana H Markovitz

P Connor Johnson

Anne Kwok

Ciara Dale

...

2023/5/1

CTIM-38. NEUROTOXICITY AND MANAGEMENT OF PRIMARY AND SECONDARY CNS LYMPHOMA AFTER ADOPTIVE IMMUNOTHERAPY WITH CD19-DIRECTED CAR T-CELLS

Neuro-Oncology

Philipp Karschnia

Isabel Arrillaga-Romany

April Eichler

Deborah Forst

Elizabeth Gerstner

...

2023/11/1

Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinoma

The Journal of Sexual Medicine

Marissa B Savoie

Alan Paciorek

Katherine Van Loon

Mekhail Anwar

Chloe E Atreya

...

2023/4

Clinical features of acute kidney injury in the early post-transplantation period following reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation

Transplantation and Cellular Therapy

Juliana Vergara-Cadavid

P Connor Johnson

Haesook T Kim

Alisha Yi

Meghan E Sise

...

2023/7/1

Immune checkpoint inhibitors-the need for innovation

N Engl J Med

P Connor Johnson

Justin F Gainor

Ryan J Sullivan

Dan L Longo

Bruce Chabner

2023/4/20

See List of Professors in Peter Johnson University(University of Bath)